Illumina Historical Income Statement

ILMN Stock

USD 144.15 0.21 0.15%

Historical analysis of Illumina income statement accounts such as Total Revenue of 4.7 B or Gross Profit of 2.9 B can show how well Illumina performed in making a profits. Evaluating Illumina income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Illumina's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Illumina latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Illumina is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

About Illumina Income Statement Analysis

Illumina Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Illumina shareholders. The income statement also shows Illumina investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Illumina Income Statement Chart

At this time, Illumina's Total Operating Expenses is very stable compared to the past year. As of the 30th of November 2024, Income Tax Expense is likely to grow to about 75 M, while Interest Expense is likely to drop about 60.3 M.

Total Revenue Gross Profit Other Operating Expenses Research Development Ebitda

Total Revenue

Total revenue comprises all receipts Illumina generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Illumina minus its cost of goods sold. It is profit before Illumina operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Illumina. It is also known as Illumina overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Illumina's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Illumina current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.At this time, Illumina's Total Operating Expenses is very stable compared to the past year. As of the 30th of November 2024, Income Tax Expense is likely to grow to about 75 M, while Interest Expense is likely to drop about 60.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	3.2B	3.0B	2.7B	2.9B
Total Revenue	4.5B	4.6B	4.5B	4.7B

Gross Profit Total Revenue

Illumina income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Selling General Administrative	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.62	0.91	0.86	0.95	-0.65	-0.65	0.98	-0.65	0.97	0.81	-0.61	-0.02	0.86	-0.6	-0.39	-0.62	0.78	-0.14	-0.43	0.16	0.03	0.88	0.76
Interest Expense	0.62		0.71	0.7	0.7	0.08	0.08	0.64	0.08	0.7	0.22	0.13	0.13	0.7	0.13	0.29	0.11	0.6	0.17	-0.24	0.33	0.0	0.43	0.61
Total Revenue	0.91	0.71		0.99	0.97	-0.46	-0.46	0.96	-0.44	0.98	0.78	-0.38	0.22	0.93	-0.36	-0.29	-0.39	0.88	0.18	-0.25	0.37	0.04	0.74	0.86
Gross Profit	0.86	0.7	0.99		0.95	-0.4	-0.41	0.92	-0.38	0.95	0.76	-0.32	0.26	0.92	-0.3	-0.27	-0.33	0.86	0.26	-0.21	0.42	0.03	0.68	0.86
Other Operating Expenses	0.95	0.7	0.97	0.95		-0.53	-0.53	0.99	-0.52	0.98	0.79	-0.44	0.09	0.97	-0.43	-0.27	-0.45	0.84	0.16	-0.34	0.43	-0.11	0.81	0.82
Operating Income	-0.65	0.08	-0.46	-0.4	-0.53		1.0	-0.62	0.99	-0.53	-0.89	0.98	0.3	-0.44	0.98	0.88	0.98	-0.33	0.3	0.44	0.0	0.1	-0.8	-0.38
Ebit	-0.65	0.08	-0.46	-0.41	-0.53	1.0		-0.62	1.0	-0.53	-0.89	0.98	0.3	-0.44	0.98	0.89	0.98	-0.31	0.31	0.44	0.01	0.11	-0.79	-0.37
Research Development	0.98	0.64	0.96	0.92	0.99	-0.62	-0.62		-0.61	0.98	0.84	-0.54	0.04	0.95	-0.53	-0.36	-0.55	0.81	0.06	-0.39	0.36	-0.09	0.86	0.8
Ebitda	-0.65	0.08	-0.44	-0.38	-0.52	0.99	1.0	-0.61		-0.52	-0.86	0.99	0.33	-0.43	0.98	0.86	0.98	-0.29	0.35	0.47	0.04	0.11	-0.8	-0.35
Cost Of Revenue	0.97	0.7	0.98	0.95	0.98	-0.53	-0.53	0.98	-0.52		0.79	-0.47	0.14	0.92	-0.45	-0.31	-0.48	0.87	0.04	-0.31	0.27	0.04	0.81	0.83
Total Operating Expenses	0.81	0.22	0.78	0.76	0.79	-0.89	-0.89	0.84	-0.86	0.79		-0.83	-0.05	0.72	-0.81	-0.79	-0.83	0.62	-0.02	-0.36	0.24	-0.06	0.83	0.66
Net Income	-0.61	0.13	-0.38	-0.32	-0.44	0.98	0.98	-0.54	0.99	-0.47	-0.83		0.34	-0.32	1.0	0.9	1.0	-0.24	0.47	0.46	0.18	0.0	-0.76	-0.3
Income Tax Expense	-0.02	0.13	0.22	0.26	0.09	0.3	0.3	0.04	0.33	0.14	-0.05	0.34		0.09	0.39	0.19	0.33	0.35	0.49	0.86	0.04	0.13	-0.24	-0.01
Selling General Administrative	0.86	0.7	0.93	0.92	0.97	-0.44	-0.44	0.95	-0.43	0.92	0.72	-0.32	0.09		-0.3	-0.15	-0.33	0.79	0.34	-0.31	0.62	-0.26	0.74	0.8
Income Before Tax	-0.6	0.13	-0.36	-0.3	-0.43	0.98	0.98	-0.53	0.98	-0.45	-0.81	1.0	0.39	-0.3		0.89	1.0	-0.22	0.49	0.5	0.19	0.0	-0.76	-0.29
Total Other Income Expense Net	-0.39	0.29	-0.29	-0.27	-0.27	0.88	0.89	-0.36	0.86	-0.31	-0.79	0.9	0.19	-0.15	0.89		0.91	-0.17	0.35	0.28	0.2	-0.13	-0.55	-0.24
Net Income From Continuing Ops	-0.62	0.11	-0.39	-0.33	-0.45	0.98	0.98	-0.55	0.98	-0.48	-0.83	1.0	0.33	-0.33	1.0	0.91		-0.25	0.47	0.46	0.18	-0.01	-0.76	-0.3
Non Recurring	0.78	0.6	0.88	0.86	0.84	-0.33	-0.31	0.81	-0.29	0.87	0.62	-0.24	0.35	0.79	-0.22	-0.17	-0.25		0.25	0.0	0.28	0.21	0.62	0.88
Non Operating Income Net Other	-0.14	0.17	0.18	0.26	0.16	0.3	0.31	0.06	0.35	0.04	-0.02	0.47	0.49	0.34	0.49	0.35	0.47	0.25		0.48	0.83	-0.44	-0.2	0.15
Tax Provision	-0.43	-0.24	-0.25	-0.21	-0.34	0.44	0.44	-0.39	0.47	-0.31	-0.36	0.46	0.86	-0.31	0.5	0.28	0.46	0.0	0.48		-0.06	0.06	-0.52	-0.37
Interest Income	0.16	0.33	0.37	0.42	0.43	0.0	0.01	0.36	0.04	0.27	0.24	0.18	0.04	0.62	0.19	0.2	0.18	0.28	0.83	-0.06		-0.65	0.15	0.34
Net Interest Income	0.03	0.0	0.04	0.03	-0.11	0.1	0.11	-0.09	0.11	0.04	-0.06	0.0	0.13	-0.26	0.0	-0.13	-0.01	0.21	-0.44	0.06	-0.65		-0.04	0.21
Reconciled Depreciation	0.88	0.43	0.74	0.68	0.81	-0.8	-0.79	0.86	-0.8	0.81	0.83	-0.76	-0.24	0.74	-0.76	-0.55	-0.76	0.62	-0.2	-0.52	0.15	-0.04		0.66
Extraordinary Items	0.76	0.61	0.86	0.86	0.82	-0.38	-0.37	0.8	-0.35	0.83	0.66	-0.3	-0.01	0.8	-0.29	-0.24	-0.3	0.88	0.15	-0.37	0.34	0.21	0.66

Click cells to compare fundamentals

Illumina Account Relationship Matchups

Illumina income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	188M	187M	251M	394M	432M	453.6M
Interest Expense	52M	49M	61M	26M	77M	60.3M
Total Revenue	3.5B	3.2B	4.5B	4.6B	4.5B	4.7B
Gross Profit	2.5B	2.2B	3.2B	3.0B	2.7B	2.9B
Other Operating Expenses	2.6B	2.7B	4.6B	4.2B	4.7B	5.0B
Operating Income	985M	393M	(123M)	(4.2B)	(1.1B)	(1.0B)
Ebit	985M	393M	(123M)	(4.2B)	(1.1B)	(1.0B)
Research Development	647M	682M	1.2B	1.3B	1.4B	1.4B
Ebitda	1.2B	580M	128M	(3.8B)	(1.1B)	(1.0B)
Cost Of Revenue	1.1B	1.0B	1.4B	1.6B	1.8B	1.8B
Total Operating Expenses	1.5B	1.6B	3.3B	7.2B	3.0B	3.1B
Net Income	1.0B	656M	762M	(4.4B)	(1.2B)	(1.1B)
Income Tax Expense	128M	200M	122M	68M	44M	75.0M
Selling General Administrative	835M	941M	2.1B	1.3B	1.6B	1.7B
Income Before Tax	1.1B	856M	884M	(4.3B)	(1.1B)	(1.1B)
Total Other Income Expense Net	133M	463M	1.0B	(8.8B)	(48M)	(50.4M)
Net Income Applicable To Common Shares	1.0B	656M	762M	(4.4B)	(4.0B)	(3.8B)
Net Income From Continuing Ops	990M	656M	762M	(4.4B)	(1.2B)	(1.1B)
Non Operating Income Net Other	185M	325M	1.1B	(157M)	(180.6M)	(171.5M)
Tax Provision	128M	200M	122M	68M	44M	41.8M
Interest Income	75M	41M	919M	11M	58M	55.1M
Net Interest Income	23M	(8M)	(61M)	(15M)	(19M)	(20.0M)
Reconciled Depreciation	188M	187M	251M	394M	432M	280.8M

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving against Illumina Stock

0.66	VCNX	Vaccinex	Pair Corr
0.49	VALN	Valneva SE ADR	Pair Corr
0.49	DRMA	Dermata Therapeutics	Pair Corr
0.48	ME	23Andme Holding Upward Rally	Pair Corr
0.34	DOMH	Dominari Holdings	Pair Corr

The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.

The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:

How To Invest In Illumina

Details

Is Illumina Stock a good investment?

Details

What is Illumina's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

(9.98)

Revenue Per Share

27.654

Quarterly Revenue Growth

(0.04)

Return On Assets

0.0262

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Illumina Historical Income Statement

About Illumina Income Statement Analysis

Illumina Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Illumina income statement Correlations

Illumina Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Illumina income statement Accounts

Pair Trading with Illumina

Moving against Illumina Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Net Income
Net Income From Continuing Ops	+ 1.0	Net Income
Net Income From Continuing Ops	+ 1.0	Income Before Tax
Gross Profit	+ 0.99	Total Revenue

Total Operating Expenses	- 0.89	Ebit
Total Operating Expenses	- 0.89	Operating Income
Total Operating Expenses	- 0.86	Ebitda
Net Income From Continuing Ops	- 0.83	Total Operating Expenses
Net Income	- 0.83	Total Operating Expenses
Income Before Tax	- 0.81	Total Operating Expenses